As part of the 2025 budget tax package, the Knesset passed an amendment that expands and increases what is sometimes known as the “Rich Man’s Tax” on high-income taxpayers.
"2024 marked a transformative year for Teva, resulting in a second consecutive year of growth, driven by our generic products and key innovative products," said Teva CEO.
"Growth in Israel is relatively high and the deficit is expected to decline and is significantly lower than most of the Western world," said Mizrahi Tefahot regional financial advisor David Shelly.
The Inter-Ministerial Tender Committee for Supplemental Treatment of Shafdan Effluents announced that seven groups submitted proposals for the international tender.
"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot be identified in one particular gene," says founder Zaks